Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 172 |
|---|
(No ratings)
Dr. Antonio Carlos Wolff, MD is an oncologist in Lutherville, MD specializing in oncology (cancer care). Dr. Antonio Carlos Wolff, MD is affiliated with Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 172 |
|---|
The top procedures that Dr. Antonio Carlos Wolff, MD treated as an oncologist in Lutherville, MD during 2013 were chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| biological response modifier (BRM) therapy | 88 |
|---|---|
| chemotherapy | 88 |
| doctor visit | 185 |
| minimally invasive procedures | 88 |
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Non-Hispanic White | 78 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 71 |
|---|---|
| From 75 to 84 | 21 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 58 |
|---|---|
| High Cholesterol | 42 |
| Stroke | 0 |
| Ischemic Heart Disease | 23 |
| Depression | 18 |
| Chronic Kidney Disease | 12 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 25 |
| Dementia | 0 |
| Cancer | 75 |
The top procedures that Dr. Antonio Carlos Wolff, MD treated as an oncologist in Lutherville, MD during 2014 were chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| biological response modifier (BRM) therapy | 76 |
|---|---|
| chemotherapy | 76 |
| doctor visit | 175 |
| minimally invasive procedures | 76 |
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Non-Hispanic White | 90 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 80 |
|---|---|
| From 75 to 84 | 23 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 63 |
|---|---|
| High Cholesterol | 44 |
| Stroke | 0 |
| Ischemic Heart Disease | 17 |
| Depression | 19 |
| Chronic Kidney Disease | 10 |
| Asthma | 0 |
| Osteoperosis | 9 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 24 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 169 |
|---|
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Non-Hispanic White | 180 |
|---|---|
| Black | 56 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 184 |
|---|---|
| From 75 to 84 | 40 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 55 |
|---|---|
| High Cholesterol | 33 |
| Stroke | 0 |
| Ischemic Heart Disease | 23 |
| Depression | 20 |
| Chronic Kidney Disease | 14 |
| Asthma | 0 |
| Osteoperosis | 11 |
| Atrial Fibrilation | 0 |
| Heart Failure | 10 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 20 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 138 |
|---|
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Non-Hispanic White | 76 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 78 |
|---|---|
| From 75 to 84 | 22 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 62 |
|---|---|
| High Cholesterol | 47 |
| Stroke | 0 |
| Ischemic Heart Disease | 25 |
| Depression | 21 |
| Chronic Kidney Disease | 15 |
| Asthma | 10 |
| Osteoperosis | 13 |
| Atrial Fibrilation | 0 |
| Heart Failure | 13 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 15 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 191 |
|---|
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Non-Hispanic White | 102 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 90 |
|---|---|
| From 75 to 84 | 32 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 65 |
|---|---|
| High Cholesterol | 41 |
| Stroke | 0 |
| Ischemic Heart Disease | 21 |
| Depression | 20 |
| Chronic Kidney Disease | 21 |
| Asthma | 9 |
| Osteoperosis | 8 |
| Atrial Fibrilation | 8 |
| Heart Failure | 14 |
| Chronic Obstructive Pulmonary Disease | 8 |
| Diabetes | 23 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 189 |
|---|
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Non-Hispanic White | 112 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 98 |
|---|---|
| From 75 to 84 | 38 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 62 |
|---|---|
| High Cholesterol | 48 |
| Stroke | 0 |
| Ischemic Heart Disease | 22 |
| Depression | 30 |
| Chronic Kidney Disease | 20 |
| Asthma | 9 |
| Osteoperosis | 15 |
| Atrial Fibrilation | 0 |
| Heart Failure | 13 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 22 |
| Dementia | 7 |
| Cancer | 75 |
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 157 |
|---|
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Non-Hispanic White | 107 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 97 |
|---|---|
| From 75 to 84 | 31 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 55 |
|---|---|
| High Cholesterol | 50 |
| Stroke | 0 |
| Ischemic Heart Disease | 29 |
| Depression | 22 |
| Chronic Kidney Disease | 22 |
| Asthma | 9 |
| Osteoperosis | 17 |
| Atrial Fibrilation | 10 |
| Heart Failure | 10 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 27 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 163 |
|---|
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Non-Hispanic White | 94 |
|---|---|
| Black | 33 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 95 |
|---|---|
| From 75 to 84 | 30 |
| 85 and over | 0 |
| Less than 65 | 15 |
| Hypertension | 59 |
|---|---|
| High Cholesterol | 50 |
| Stroke | 0 |
| Ischemic Heart Disease | 26 |
| Depression | 21 |
| Chronic Kidney Disease | 24 |
| Asthma | 9 |
| Osteoperosis | 18 |
| Atrial Fibrilation | 8 |
| Heart Failure | 14 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 26 |
| Dementia | 0 |
| Cancer | 75 |
The top procedures that Dr. Antonio Carlos Wolff, MD treated as an oncologist in Lutherville, MD during 2021 were hospital care and inpatient care.
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 160 |
|---|---|
| hospital care | 60 |
| inpatient care | 60 |
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Male | 11 |
|---|---|
| Female | 137 |
| Non-Hispanic White | 109 |
|---|---|
| Black | 28 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 92 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 64 |
|---|---|
| High Cholesterol | 51 |
| Stroke | 0 |
| Ischemic Heart Disease | 23 |
| Depression | 21 |
| Chronic Kidney Disease | 24 |
| Asthma | 0 |
| Osteoperosis | 20 |
| Atrial Fibrilation | 7 |
| Heart Failure | 13 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 25 |
| Dementia | 0 |
| Cancer | 75 |
The top procedures that Dr. Antonio Carlos Wolff, MD treated as an oncologist in Lutherville, MD during 2022 were hospital care and inpatient care.
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 150 |
|---|---|
| hospital care | 71 |
| inpatient care | 71 |
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Male | 14 |
|---|---|
| Female | 142 |
| Non-Hispanic White | 111 |
|---|---|
| Black | 32 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 89 |
|---|---|
| From 75 to 84 | 47 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 68 |
|---|---|
| High Cholesterol | 72 |
| Stroke | 0 |
| Ischemic Heart Disease | 18 |
| Depression | 23 |
| Chronic Kidney Disease | 17 |
| Asthma | 12 |
| Osteoperosis | 25 |
| Atrial Fibrilation | 11 |
| Heart Failure | 12 |
| Chronic Obstructive Pulmonary Disease | 12 |
| Diabetes | 26 |
| Dementia | 0 |
| Cancer | 75 |
The top procedures that Dr. Antonio Carlos Wolff, MD treated as an oncologist in Lutherville, MD during 2023 were hospital care and inpatient care.
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| doctor visit | 183 |
|---|---|
| hospital care | 113 |
| inpatient care | 113 |
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Male | 21 |
|---|---|
| Female | 145 |
| Non-Hispanic White | 119 |
|---|---|
| Black | 31 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 99 |
|---|---|
| From 75 to 84 | 41 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 70 |
|---|---|
| High Cholesterol | 69 |
| Stroke | 0 |
| Ischemic Heart Disease | 20 |
| Depression | 23 |
| Chronic Kidney Disease | 15 |
| Asthma | 10 |
| Osteoperosis | 24 |
| Atrial Fibrilation | 11 |
| Heart Failure | 14 |
| Chronic Obstructive Pulmonary Disease | 10 |
| Diabetes | 22 |
| Dementia | 0 |
| Cancer | 75 |
The top procedures that Dr. Antonio Carlos Wolff, MD treated as an oncologist in Lutherville, MD during 2024 were chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
| biological response modifier (BRM) therapy | 81 |
|---|---|
| chemotherapy | 81 |
| doctor visit | 206 |
| minimally invasive procedures | 81 |
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Non-Hispanic White | 96 |
|---|---|
| Black | 33 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 75 |
|---|---|
| From 75 to 84 | 42 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 63 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 0 |
| Ischemic Heart Disease | 14 |
| Depression | 19 |
| Chronic Kidney Disease | 12 |
| Asthma | 12 |
| Osteoperosis | 29 |
| Atrial Fibrilation | 10 |
| Heart Failure | 9 |
| Chronic Obstructive Pulmonary Disease | 8 |
| Diabetes | 19 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Antonio Carlos Wolff, MD for Medicare patients.
The highest averages for the top procedures that Dr. Antonio Carlos Wolff, MD treated as an oncologist in Lutherville, MD were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and hospital care.
| biological response modifier (BRM) therapy | 81 |
|---|---|
| chemotherapy | 81 |
| doctor visit | 172 |
| hospital care | 81 |
| inpatient care | 81 |
| minimally invasive procedures | 81 |
Information about Medicare patients treated by Dr. Antonio Carlos Wolff, MD.
| Female | 32 |
|---|---|
| Male | 3 |
| Black / African American | 16 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 98 |
| Hispanic | 0 |
| Native American / Alaskan Native | 0 |
| Other | 0 |
| 85 and over | 0 |
|---|---|
| 75 to 84 | 28 |
| Less than 65 | 1 |
| 65 to 74 | 88 |
The highest averages of the most common conditions of Medicare patients that Dr. Antonio Carlos Wolff, MD treated were cancer, hypertension, high cholesterol and diabetes.
| Hypertension | 57 |
|---|---|
| High Cholesterol | 47 |
| Stroke | 0 |
| Ischemic Heart Disease | 20 |
| Depression | 19 |
| Chronic Kidney Disease | 15 |
| Asthma | 6 |
| Osteoporosis | 14 |
| Heart Failure | 9 |
| Chronic Obstructive Pulmonary Disease | 2 |
| Diabetes | 21 |
| Atrial Fibrillation | 5 |
| Dementia | 0 |
| Cancer | 69 |
He has a state license in Maryland.
Licensed In: Maryland
Dr. Antonio Carlos Wolff, MD does not have any reviews yet, be the first to leave a review of Dr. Antonio Carlos Wolff, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Antonio Carlos Wolff, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| F. Hoffmann-La Roche AG |
$3,300
TECENTRIQ $3,300 |
|||
|---|---|---|---|---|
| Pfizer Inc. |
$747
$747 |
|||
| AstraZeneca UK Limited |
$243
$243 |
|||
| Novartis Pharmaceuticals Corporation |
$221
TYKERB $122 |
$99 |
||
| AstraZeneca Pharmaceuticals LP |
$100
$100 |
|||
| Other |
$115
Herceptin $76 |
LAP016 $16 |
Proleukin $11 |
$12 |
| Consulting Fee | $3,665 |
|---|---|
| Food and Beverage | $939 |
| Travel and Lodging | $99 |
| Education | $22 |
Dr. Antonio Carlos Wolff, MD has received 103 research payments totaling $1,180,588.
Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine.